Radcliffe Capital Management’s Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares DNAB Stock Holding History

Radcliffe Capital Management’s Portfolio DNAB Stock Details DNAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-450,616	Closed	-$4.66M	–	586
2023 Q2	$4.66M	Hold	450,616	–	–	0.4%	73
2023 Q1	$4.61M	Buy	450,616 +42,440	+10%	+$431K	0.29%	108
2022 Q4	$4.11M	Hold	408,176	–	–	0.13%	247
2022 Q3	$4M	Buy	408,176 +277	+0.1%	+$2.71K	0.1%	365
2022 Q2	$3.96M	Buy	407,899 +272,836	+202%	+$2.65M	0.09%	378
2022 Q1	$1.32M	Buy	135,063 +10,063	+8%	+$97.7K	0.03%	837
2021 Q4	$1.24M	Hold	125,000	–	–	0.03%	755
2021 Q3	$1.24M	Hold	125,000	–	–	0.04%	641
2021 Q2	$1.26M	Buy	+125,000	New	+$1.26M	0.04%	656

Radcliffe Capital Management's DNAB Position: Q3 2023 in Review

Radcliffe Capital Management sold out of Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares (DNAB) in Q3 2023, closing a stake of 450,616 shares — an estimated $4.66M sold.

Radcliffe Capital Management first reported a position in DNAB in Q2 2021 and held it in 9 quarters. The position peaked at $4.66M in Q2 2023. 0 funds tracked by Wall St. Rank hold DNAB as of Q3 2023.

Radcliffe Capital Management reported no remaining Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Radcliffe Capital Management sold 450,616 Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares shares in Q3 2023, an estimated $4.66M.
Radcliffe Capital Management first reported a position in Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares in Q2 2021 and held it in 9 quarters.
Radcliffe Capital Management's Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares position peaked at $4.66M in Q2 2023.
0 funds tracked by Wall St. Rank held Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares as of Q3 2023.

Based on Radcliffe Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.